Healthcare Professionals Courses- Beyond Basic Level 2: Chapter 7
For those involved in the day to day running of clinical trials across all functions
Clinical Trial Process
Level 2
-
1
Module 1: Site Selection for a Trial
-
slide 2
-
slide 3
-
slide 4
-
slide 5
-
slide 6
-
slide 7
-
slide 8_1
-
Knowledge Checkpoints 01
-
slide 9_2
-
slide 10_1
-
slide 11
-
slide 12_1
-
slide 13_1
-
slide 14_1
-
slide 15_2
-
slide 16_1
-
Knowledge Checkpoints 02
-
slide 17_2
-
slide 18_1
-
slide 19
-
slide 20
-
slide 21
-
slide 22
-
Knowledge Checkpoints 03
-
slide 23
-
-
2
Module 2: Trial Start-up Requirements: From Site Selection to Site Initiation
-
slide 2
-
slide 3
-
slide 4_1
-
slide 5
-
slide 6_1
-
slide 7
-
Knowledge Checkpoint 01
-
slide 8_1
-
slide 9_1
-
slide 10
-
slide 11
-
slide 12_1
-
Knowledge Checkpoint 02
-
slide 13_1
-
slide 14_1
-
slide 15
-
slide 16_1
-
slide 17
-
slide 18_1
-
Knowledge Checkpoint 03
-
slide 19
-
-
3
Module 3: Trial Active Stage: Managing the Subjects and Monitoring
-
slide 2
-
slide 3_1
-
slide 4
-
slide 5_1
-
slide 6_1
-
Knowledge Checkpoints 01
-
slide 7_2
-
slide 8_1
-
slide 9
-
slide 10_1
-
slide 11
-
slide 12
-
slide 13_1
-
slide 14_1
-
Knowledge Checkpoints 02
-
slide 15_1
-
slide 16_1
-
slide 17
-
slide 18_1
-
slide 19_1
-
slide 20_1
-
slide 21_1
-
slide 22_1_1
-
slide 23
-
Knowledge Checkpoints 03
-
slide 24_1
-
-
4
Module 4: After patient completion: Responsibilities for the data, the documents and reporting results
-
slide 2
-
slide 3_1
-
slide 4_1
-
slide 5
-
slide 6
-
Knowledge Checkpoints 01
-
slide 7
-
slide 8_1
-
slide 9_4
-
slide 10_1
-
slide 11_1
-
Knowledge Checkpoints 02
-
slide 12
-
-
5
Module 5: Trial Master File and Site Files – Design, Management and Archiving
-
slide 2
-
slide 3
-
slide 4
-
slide 5
-
slide 6
-
slide 7
-
slide 8
-
slide 9
-
Knowledge Checkpoints 1
-
slide 10
-
slide 11
-
slide 12
-
slide 13
-
Knowledge Checkpoints 2
-
slide 14
-
slide 15
-
slide 16
-
slide 17
-
slide 18
-
slide 19
-
slide 20
-
slide 21
-
slide 22
-
slide 23
-
slide 24
-
Knowledge Checkpoints 3
-
slide 25
-
Instructor
Chief Operating Officer
Dr Tina Barton
Dr. Tina Barton, Chief Operating Officer of eMQT, is a drug development specialist with over 40 years’ experience, working in partnership to lead for success as a customer-focused senior leader. During this time Dr. Barton has invested in training for the future – through team leadership, individual mentoring and training thereby sharing knowledge and developing professionals. Through her role at the Institute of Clinical Research she continues to support and lead training activities. With a passion for transformation, Dr. Barton drove the embracement of Central Eastern European countries and now is focused on the inclusion of Sub-Saharan Africa into clinical development – bringing the miracle of development of new medicines to emerging markets and new patients. Dr. Barton holds a BSc, PhD and MBA alongside over 50 academic publications and is an Honorary Fellow, and Board Member of the Institute of Clinical Research.
Email